Avicanna (AVCNF, $0.2) was a top loser over the last three months, falling to $0.2 per share. A.I.dvisor analyzed 226 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending December 23, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.